Abstract:The nose-to-brain drug-delivery system has emerged as a promising strategy to overcome the challenges associated with conventional drug administration for central nervous system disorders. This emerging field is driven by the anatomical advantages of the nasal route, enabling the direct transport of drugs from the nasal cavity to the brain, thereby circumventing the blood–brain barrier. This review highlights the significance of the anatomical features of the nasal cavity, emphasizing its high permeability and rich blood supply that facilitate rapid drug absorption and onset of action, rendering it a promising domain for neurological therapeutics. Exploring recent developments and innovations in different nanocarriers such as liposomes, polymeric nanoparticles, solid lipid nanoparticles, dendrimers, micelles, nanoemulsions, nanosuspensions, carbon nanotubes, mesoporous silica nanoparticles, and nanogels unveils their diverse functions in improving drug-delivery efficiency and targeting specificity within this system. To minimize the potential risk of nanoparticle-induced toxicity in the nasal mucosa, this article also delves into the latest advancements in the formulation strategies commonly involving surface modifications, incorporating cutting-edge materials, the adjustment of particle properties, and the development of novel formulations to improve drug stability, release kinetics, and targeting specificity. These approaches aim to enhance drug absorption while minimizing adverse effects. These strategies hold the potential to catalyze the advancement of safer and more efficient nose-to-brain drug-delivery systems, consequently revolutionizing treatments for neurological disorders. This review provides a valuable resource for researchers, clinicians, and pharmaceutical-industry professionals seeking to advance the development of effective and safe therapies for central nervous system disorders.

Clinical Trials of Intranasal Delivery for Treating Neurological Disorders – a Critical Review

Chances and Challenges in Intranasal Administration Delivery for Brain Disease Treatment

Intranasal Delivery: Circumventing the Iron Curtain to Treat Neurological Disorders

Evaluation of Recent Intranasal Drug Delivery Systems to the Central Nervous System

Therapeutic Potential Of Intranasal Delivery Of Drugs And Cells For Stroke And Other Neurological Diseases

Intranasal drug delivery: opportunities and toxicologic challenges during drug development

An overview of in vitro and in vivo techniques for characterization of intranasal protein and peptide formulations for brain targeting

Updated Progress of Nanocarrier-Based Intranasal Drug Delivery Systems for Treatment of Brain Diseases

Intranasal Administration: a Potential Solution for Cross-Bbb Delivering Neurotrophic Factors.

Intranasal Delivery of Stem Cells to the Brain

Research progress in brain-targeted nasal drug delivery

Nanotechnology for enhanced nose-to-brain drug delivery in treating neurological diseases

Intranasal drug delivery: The interaction between nanoparticles and the nose-to-brain pathway

Nose-to-brain delivery of nanotherapeutics: Transport mechanisms and applications

Technological Strategies Applied to Pharmaceutical Systems for Intranasal Administration of Drugs Intended for Neurological Treatments: A Review

Advances and future perspectives of intranasal drug delivery: A scientometric review

Nasal Delivery to the Brain: Harnessing Nanoparticles for Effective Drug Transport

Pharmacokinetics and Pharmacodynamics of Intranasal Solid Lipid Nanoparticles and Nanostructured Lipid Carriers for Nose-to-Brain Delivery

Nose-to-Brain (N2B) Delivery: An Alternative Route for the Delivery of Biologics in the Management and Treatment of Central Nervous System Disorders

Non-Invasive Techniques of Nose to Brain Delivery Using Nanoparticulate Carriers: Hopes and Hurdles

Biomedical applications of artificial exosomes for intranasal drug delivery